Literature DB >> 9604545

The influence of alpha-thalassaemia on the haematological & clinical expression of sickle cell disease in western India.

M B Mukherjee1, R Surve, A Tamankar, R R Gangakhedkar, K Ghosh, C Y Lu, R Krishnamoorthy, R Colah, D Mohanty.   

Abstract

We evaluated the clinical and haematological features of 29 sickle cell anaemia patients with associated alpha-thalassaemia and 22 sickle cell homozygotes with a normal alpha-globin genotype from western India. The presence of alpha-thalassaemia resulted in significantly higher haemoglobin (Hb), haematocrit (HCT), red blood cells counts (RBC) and haemoglobin A2 (HbA2) levels but lower mean cell haemoglobin (MCH) and mean cell volume (MCV). The clinical presentation in these patients was also milder with fewer episodes of painful crisis, chest syndromes, infections, requirement of hospitalization and blood transfusions. However, splenomegaly was more common as compared to the patients with a normal alpha-globin genotype. It is evident from the present study that alpha-thalassaemia could be an important genetic factor modulating the clinical expression and haematological severity of sickle cell anaemia in this region.

Entities:  

Mesh:

Year:  1998        PMID: 9604545

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


  6 in total

Review 1.  Advances in management of sickle cell disease.

Authors:  M B Agarwal
Journal:  Indian J Pediatr       Date:  2003-08       Impact factor: 1.967

2.  Sickle cell anemia--molecular diagnosis and prenatal counseling: SGPGI experience.

Authors:  Ravindra Kumar; Inusha Panigrahi; Ashwin Dalal; Sarita Agarwal
Journal:  Indian J Pediatr       Date:  2011-06-29       Impact factor: 1.967

3.  Alpha thalassemia among sickle cell anaemia patients in Kampala, Uganda.

Authors:  Irene Lubega; Christopher M Ndugwa; Edison A Mworozi; James K Tumwine
Journal:  Afr Health Sci       Date:  2015-06       Impact factor: 0.927

Review 4.  Differences in the clinical and genotypic presentation of sickle cell disease around the world.

Authors:  Santosh L Saraf; Robert E Molokie; Mehdi Nouraie; Craig A Sable; Lori Luchtman-Jones; Gregory J Ensing; Andrew D Campbell; Sohail R Rana; Xiao M Niu; Roberto F Machado; Mark T Gladwin; Victor R Gordeuk
Journal:  Paediatr Respir Rev       Date:  2013-11-15       Impact factor: 2.726

5.  β-Globin chain abnormalities with coexisting α-thalassemia mutations.

Authors:  Birol Guvenc; Abdullah Canataroglu; Cagatay Unsal; Sule Menziletoglu Yildiz; Ferda Tekin Turhan; Sevcan Tug Bozdogan; Suleyman Dincer; Hakan Erkman
Journal:  Arch Med Sci       Date:  2012-05-29       Impact factor: 3.318

6.  Retained Splenic Function in an Indian Population with Homozygous Sickle Cell Disease May Have Important Clinical Significance.

Authors:  Beryl Serjeant; Ian Hambleton; Graham Serjeant
Journal:  Indian J Community Med       Date:  2021-12-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.